Amicoat provides partners with comprehensive support to develop antimicrobial medical devices from idea to launch
Versatile technology platform – partnerships across the medical device industry
Amicoat’s antimicrobial technology voxvoganan and its associated application methods are applicable across a range of materials used in medical devices. As a consequence, we are able to provide next-generation antimicrobial properties to almost any medical device.
This makes Amicoat a suitable partner to explore how to make antimicrobial effect a key characteristic and differentiator across our partners’ complete medical device portfolio.
Product development – support across all phases
Coupling our extensive knowledge on our antimicrobial peptide voxvoganan and coating methods with your understanding of the product, we together develop optimal products.
Our scientists support in testing the feasibility of incorporating voxvoganan as the antimicrobial technology by developing a suitable coating methodology and microbiological assessments.
Regulatory support – an enabler for market access
Our comprehensive regulatory package provides a solid foundation for the regulatory approval of the medical device, based on comprehensive non-clinical and clinical tests in addition to a solid foundation of published research.
Want to discuss how Amicoat can bring the next-generation antimicrobial technology into your medical device portfolio?
Njål Tage Gjerdalen
Vice President Business Development
Erik Møller Steen
Business Development Manager
